Taiwan FDA registration 0160658e50b9786fc45d7da644e1f93e
Beckman Coulter IO detects IgG2a isotype control antibodies
TW: 貝克曼庫爾特IO檢測IgG2a 同型控制抗體
Taiwan·Risk Class 2·IMMUNOTECH SAS, A BECKMAN COULTER COMPANY·Registered Sep 29, 2006 – Sep 29, 2026ActiveRegistration details
- Analysis ID
- 0160658e50b9786fc45d7da644e1f93e
- Customs Code
- DHA00601754800
Company information
- Manufacturer
- IMMUNOTECH SAS, A BECKMAN COULTER COMPANY
- Manufacturer Country
- France
- Authorized Representative
- BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- It is used to determine the non-specific binding ability of homotype antibody (IgG2a) to cells, and to determine the background fluorescence value.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5220 Automatic Differentiation Cell Counter
- Import Information
- import
Dates and status
- Registration Date
- Sep 29, 2006
- Expiry Date
- Sep 29, 2026
About this record
Access comprehensive regulatory information for Beckman Coulter IO detects IgG2a isotype control antibodies in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0160658e50b9786fc45d7da644e1f93e and manufactured by IMMUNOTECH SAS, A BECKMAN COULTER COMPANY. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices